N/A
N=41
Use of High Flow Nasal Cannula During Sedation of Morbidly Obese Patients in the Endoscopy Suite
Morbid Obesity · Noninvasive Ventilation · Deep Sedation
Bottom Line
View on ClinicalTrials.gov: NCT02859597 ↗Enrolled (actual)
41
Serious AEs
0.0%
Results posted
Apr 2020
Primary outcome: Primary: Ability to Maintain Oxygenation — 0.55; 0.61 manipulations
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- High flow nasal cannula (Device); Nasal Cannula (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Montefiore Medical Center
- Primary completion
- Sep 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Ability to Maintain Oxygenation |
0.55; 0.61 | — |
| SECONDARY Number of Participants Requiring Airway Adjuncts During Procedure |
0; 0 | — |
| SECONDARY Number of Participants Who Need an Increase in Fraction of Inspired Oxygen |
6; 3 | — |
Summary
This study evaluates the ability of high flow nasal cannula versus nasal cannula to oxygenate morbidly obese patients undergoing moderate to deep sedation for gastrointestinal procedures.
Eligibility Criteria
Inclusion Criteria
- Body Mass Index greater than or equal to 40
- Scheduled for a gastrointestinal endoscopy that requires MAC sedation
Exclusion Criteria
- Body Mass Index less than 40
- Pregnant
- Require either invasive or non-invasive ventilation for respiratory failure
- Use home oxygen
- Ventilation is via a tracheostomy
- The procedure is emergent
Data sourced from ClinicalTrials.gov (NCT02859597). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.